Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

388 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lifetime risk of melanoma in CDKN2A mutation carriers in a population-based sample.
Begg CB, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Mitra N, Busam K, From L, Berwick M; Genes Environment and Melanoma Study Group. Begg CB, et al. Among authors: zanetti r. J Natl Cancer Inst. 2005 Oct 19;97(20):1507-15. doi: 10.1093/jnci/dji312. J Natl Cancer Inst. 2005. PMID: 16234564 Free article.
Vitamin D receptor polymorphisms in patients with cutaneous melanoma.
Orlow I, Roy P, Reiner AS, Yoo S, Patel H, Paine S, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Thomas NE, Gruber SB, Anton-Culver H, Rosso S, Gallagher RP, Dwyer T, Kanetsky PA, Busam K, From L, Begg CB, Berwick M; GEM Study Group. Orlow I, et al. Int J Cancer. 2012 Jan 15;130(2):405-18. doi: 10.1002/ijc.26023. Epub 2011 Apr 25. Int J Cancer. 2012. PMID: 21365644 Free PMC article.
Risk of non-melanoma cancers in first-degree relatives of CDKN2A mutation carriers.
Mukherjee B, Delancey JO, Raskin L, Everett J, Jeter J, Begg CB, Orlow I, Berwick M, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Culver HA, Rosso S, Zanetti R, Kanetsky PA, From L, Gruber SB; GEM Study Investigators. Mukherjee B, et al. Among authors: zanetti r. J Natl Cancer Inst. 2012 Jun 20;104(12):953-6. doi: 10.1093/jnci/djs221. Epub 2012 Apr 24. J Natl Cancer Inst. 2012. PMID: 22534780 Free PMC article.
Inherited genetic variants associated with occurrence of multiple primary melanoma.
Gibbs DC, Orlow I, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group. Gibbs DC, et al. Among authors: zanetti r. Cancer Epidemiol Biomarkers Prev. 2015 Jun;24(6):992-7. doi: 10.1158/1055-9965.EPI-14-1426. Epub 2015 Apr 2. Cancer Epidemiol Biomarkers Prev. 2015. PMID: 25837821 Free PMC article.
Vitamin D receptor polymorphisms and survival in patients with cutaneous melanoma: a population-based study.
Orlow I, Reiner AS, Thomas NE, Roy P, Kanetsky PA, Luo L, Paine S, Armstrong BK, Kricker A, Marrett LD, Rosso S, Zanetti R, Gruber SB, Anton-Culver H, Gallagher RP, Dwyer T, Busam K, Begg CB, Berwick M; GEM Study Group. Orlow I, et al. Among authors: zanetti r. Carcinogenesis. 2016 Jan;37(1):30-8. doi: 10.1093/carcin/bgv157. Epub 2015 Oct 31. Carcinogenesis. 2016. PMID: 26521212 Free PMC article.
Association of Interferon Regulatory Factor-4 Polymorphism rs12203592 With Divergent Melanoma Pathways.
Gibbs DC, Orlow I, Bramson JI, Kanetsky PA, Luo L, Kricker A, Armstrong BK, Anton-Culver H, Gruber SB, Marrett LD, Gallagher RP, Zanetti R, Rosso S, Dwyer T, Sharma A, La Pilla E, From L, Busam KJ, Cust AE, Ollila DW, Begg CB, Berwick M, Thomas NE; GEM Study Group. Gibbs DC, et al. Among authors: zanetti r. J Natl Cancer Inst. 2016 Feb 8;108(7):djw004. doi: 10.1093/jnci/djw004. Print 2016 Jul. J Natl Cancer Inst. 2016. PMID: 26857527 Free PMC article.
Familial aggregation of melanoma risks in a large population-based sample of melanoma cases.
Begg CB, Hummer A, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Klotz JB, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Berwick M; GEM Study Group. Begg CB, et al. Among authors: zanetti r. Cancer Causes Control. 2004 Nov;15(9):957-65. doi: 10.1007/s10522-004-2474-2. Cancer Causes Control. 2004. PMID: 15577298 Free article.
A design for cancer case-control studies using only incident cases: experience with the GEM study of melanoma.
Begg CB, Hummer AJ, Mujumdar U, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Culver HA, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Busam K, From L, Berwick M; GEM Study Group. Begg CB, et al. Among authors: zanetti r. Int J Epidemiol. 2006 Jun;35(3):756-64. doi: 10.1093/ije/dyl044. Epub 2006 Mar 23. Int J Epidemiol. 2006. PMID: 16556646
The prevalence of CDKN2A germ-line mutations and relative risk for cutaneous malignant melanoma: an international population-based study.
Berwick M, Orlow I, Hummer AJ, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Busam K, From L, Mujumdar U, Wilcox H, Begg CB; GEM Study Group. Berwick M, et al. Among authors: zanetti r. Cancer Epidemiol Biomarkers Prev. 2006 Aug;15(8):1520-5. doi: 10.1158/1055-9965.EPI-06-0270. Cancer Epidemiol Biomarkers Prev. 2006. PMID: 16896043
CDKN2A germline mutations in individuals with cutaneous malignant melanoma.
Orlow I, Begg CB, Cotignola J, Roy P, Hummer AJ, Clas BA, Mujumdar U, Canchola R, Armstrong BK, Kricker A, Marrett LD, Millikan RC, Gruber SB, Anton-Culver H, Zanetti R, Gallagher RP, Dwyer T, Rebbeck TR, Kanetsky PA, Wilcox H, Busam K, From L, Berwick M; GEM Study Group. Orlow I, et al. Among authors: zanetti r. J Invest Dermatol. 2007 May;127(5):1234-43. doi: 10.1038/sj.jid.5700689. Epub 2007 Jan 11. J Invest Dermatol. 2007. PMID: 17218939 Free article.
388 results